Venus Concept Inc stock (US92332W1053): Trading at 1.14 USD on Nasdaq

Venus Concept Inc shares traded at 1.140 USD on Nasdaq on May 12, 2026, showing 0.00% change during market hours, according to TradingKey as of 05/12/2026. The medical aesthetics company specializes in innovative devices for skin treatments and hair removal, maintaining steady trading amid broader industry growth projections.

As of: 12.05.2026

By the editorial team – specialized in equity coverage.

Venus Concept Inc: core business model

Venus Concept Inc develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies. The company's platform includes devices like Venus Versa, Venus Legacy, and Venus Viva, targeting skin resurfacing, body contouring, and hair removal procedures. These products are used by aesthetic clinics worldwide, with a focus on subscription-based business models for recurring revenue.

Founded in 2001 and headquartered in Toronto, Canada, Venus Concept went public on Nasdaq under ticker VERO. The firm emphasizes technological innovation in radiofrequency (RF) and pulsed magnetic fields to stimulate collagen production without surgery. Revenue stems primarily from device sales and ongoing service contracts, providing visibility for US investors interested in medtech growth.

Main revenue and product drivers for Venus Concept Inc

Key products include the Venus Bliss for fat reduction and the Venus Epileve for hair removal, aligning with rising demand in non-invasive beauty treatments. The global hair removal devices market is projected to reach USD 3.32 billion by 2035, driven by beauty consciousness and IPL advancements, according to GlobeNewswire as of 05/12/2026. Venus Concept benefits from this trend through its RF-based solutions.

Recurring revenue from device subscriptions and consumables accounts for a significant portion of sales, reported in prior financials for the fiscal year ended December 31, 2024, published in 2025 filings. The company operates in over 60 countries, with North America contributing substantially, offering exposure to US consumer spending on aesthetics.

Industry trends and competitive position

The RF beauty equipment market is set to grow from USD 568.4 million in 2026 to USD 933.7 million by 2033, fueled by collagen-stimulating technologies, per openPR as of recent report. Venus Concept competes with players like InMode and Lumenis, differentiating via its AI-enhanced platforms and physician-led sales model.

For US investors, the company's Nasdaq listing and focus on outpatient procedures tie into rising elective medtech demand post-pandemic. Market stability supports VERO's current 1.14 USD price point.

Why Venus Concept Inc matters for US investors

Listed on Nasdaq, Venus Concept provides US retail investors direct access to the expanding $10+ billion US medical aesthetics market. Its devices cater to dermatologists and medspas, sectors buoyed by consumer trends in anti-aging and body sculpting amid economic recovery.

Conclusion

Venus Concept Inc maintains a steady share price at 1.14 USD on Nasdaq, supported by its role in the growing medical aesthetics sector. With innovations in RF and hair removal technologies, the company positions itself amid favorable market forecasts. US investors monitor its subscription model and international expansion for sustained relevance.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.